ARIAD PHARMACEUTICALS INC 4
4 · ARIAD PHARMACEUTICALS INC · Filed Oct 5, 2016
Insider Transaction Report
Form 4
Bollag Daniel M
Sr. VP, Reg. Affairs & Quality
Transactions
- Sale
Common Stock
2016-10-03$13.46/sh−47,384$637,812→ 129,404 total
Footnotes (2)
- [F1]Shares were sold pursuant to a Rule 10b5-1 trading plan dated June 15, 2016
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.33 to $13.65 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer,or the staff of the Securities and Exchange Commission, upon request, full information regarding the shares sold at each separate price within the range set forth in this footnote.